生物标志物 生物标志物
Robert Lin1, Hien Nguyen1, Jason Wan1
1Taudia, PALO ALTO, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
我们开发了一种用于阿尔茨海默病 (AD) 的新型诊断平台,使用双联近距离结合试验 (dcPLA). 这种自动化系统提供了一种更快,更少的侵入性方法来检测像pTau-217这样的关键生物标志物,从而改善患者的结果.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 诊断技术 诊断技术的使用
背景情况:
- 基于血液的生物标志物 (BBMs) 与阿尔茨海默病 (AD) 的传统方法 (如PET和CSF测试) 相比,具有优势.
- 酸217 (pTau-217) 是一种高度特异性和临床相关的AD生物标志物.
- 对于神经退行性疾病,需要一个样本到答案,多重复合的诊断平台.
研究的目的:
- 推出首个专门为阿尔茨海默氏病 (AD) 设计的样本到答案复合诊断平台.
- 解决自动神经退行症诊断平台的市场可用性差距.
主要方法:
- 开发一种新的抗体修饰方法,与基于珠子的测试相结合,以提高近距离结合测试 (PLA) 的灵敏度和特异性.
- 实施专利双联PLA (dcPLA) 策略,简化工作流程,并允许与样本到答案系统直接集成.
- 用其他抗体证明平台适应性,以扩展菜单.
主要成果:
- 在人体血样本中检测和量化内源性pTau-217水平,使用高一致性和信号与噪声比的dcPLA.
- 成功演示了一个完全自动化的样本到答案诊断平台,并简化了工作流程.
- 该平台在大约五小时内处理多达48个样本,没有实践时间后加载,在自动化尖峰和恢复实验中显示近100%的恢复.
结论:
- 介绍了第一个以AD为重点的诊断平台,将FDA批准的样本到答案系统与dcPLA技术集成在一起.
- 该平台可实现最小侵入性和可扩展性测试,可能有助于药物开发商在临床试验中招募患者.
- 这项技术有望推进早期AD检测,纵向监测和个性化治疗策略.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516